BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10688671)

  • 21. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
    Prasad KS; Brandt SJ
    J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
    Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
    J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins.
    Doyle K; Zhang Y; Baer R; Bina M
    J Biol Chem; 1994 Apr; 269(16):12099-105. PubMed ID: 8163514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
    Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
    Gould KA; Bresnick EH
    Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
    Tang T; Prasad KS; Koury MJ; Brandt SJ
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells.
    Deed RW; Jasiok M; Norton JD
    J Biol Chem; 1998 Apr; 273(14):8278-86. PubMed ID: 9525934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
    Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
    Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of three new components of the mSin3A corepressor complex.
    Fleischer TC; Yun UJ; Ayer DE
    Mol Cell Biol; 2003 May; 23(10):3456-67. PubMed ID: 12724404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase activity is required for full transcriptional repression by mSin3A.
    Hassig CA; Fleischer TC; Billin AN; Schreiber SL; Ayer DE
    Cell; 1997 May; 89(3):341-7. PubMed ID: 9150133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
    Ono Y; Fukuhara N; Yoshie O
    J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.